Differences in lipidomics may be potential biomarkers for early diagnosis of pancreatic cancer

PURPOSE: To analyze the plasma lipid spectrum between healthy control and patients with pancreatic cancer and to select differentially expressed tumor markers for early diagnosis. METHODS: In total, 20 patents were divided into case group and healthy control group according to surgical pathology. Of...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Acta Cir Bras
Κύριοι συγγραφείς: Zhou, Dehua, Mu, Di, Cheng, Ming, Dou, Yuting, Zhang, Xianwei, Feng, Zhensheng, Qiu, Guangting, Yu, Hua, Chen, Yang, Xu, Hong, Sun, Jian, Zhou, Ling
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia 2020
Θέματα:
Clinical Investigation
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7341992/
https://ncbi.nlm.nih.gov/pubmed/32638847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/s0102-865020200050000008
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια